Never Event Loading dose Normal GFR Patient- Centered care Quality improvement Informatics Free! Metabolism Therapeutic effect Pharmacodynamics Normal ALT Therapeutic classification Potency Half- life Normal BUN Always Event Caring PICO Pharmacologic classification Therapeutic index Antagonist drug National Patient Safety Goal Evidence- based practice Agonist drug HIPAA First- Pass effect Quality assurance Incompatible Peak action Antagonistic effects Sensoristasis Systematic review The Joint Commission Bioavailability Pharmacokinetics Peak and Trough levels Efficacy Side effect RACE Synergistic effects Duration of action Additive effects Sensory Perception Onset of action Adverse effect Never Event Loading dose Normal GFR Patient- Centered care Quality improvement Informatics Free! Metabolism Therapeutic effect Pharmacodynamics Normal ALT Therapeutic classification Potency Half- life Normal BUN Always Event Caring PICO Pharmacologic classification Therapeutic index Antagonist drug National Patient Safety Goal Evidence- based practice Agonist drug HIPAA First- Pass effect Quality assurance Incompatible Peak action Antagonistic effects Sensoristasis Systematic review The Joint Commission Bioavailability Pharmacokinetics Peak and Trough levels Efficacy Side effect RACE Synergistic effects Duration of action Additive effects Sensory Perception Onset of action Adverse effect
(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.
Never Event
Loading dose
Normal GFR
Patient-Centered care
Quality improvement
Informatics
Free!
Metabolism
Therapeutic effect
Pharmacodynamics
Normal ALT
Therapeutic classification
Potency
Half-life
Normal BUN
Always Event
Caring
PICO
Pharmacologic classification
Therapeutic index
Antagonist drug
National Patient Safety Goal
Evidence-based practice
Agonist drug
HIPAA
First-Pass effect
Quality assurance
Incompatible
Peak action
Antagonistic effects
Sensoristasis
Systematic review
The Joint Commission
Bioavailability
Pharmacokinetics
Peak and Trough levels
Efficacy
Side effect
RACE
Synergistic effects
Duration of action
Additive effects
Sensory Perception
Onset of action
Adverse effect